Leronlimab, a humanized monoclonal antibody to CCR5, restrains breast cancer metastasis and enhances cell death induced by DNA damaging chemotherapies-MedSci.cn

Leronlimab, a humanized monoclonal antibody to CCR5, restrains breast cancer metastasis and enhances cell death induced by DNA damaging chemotherapies

Pestell, RG; Cristofanilli, M; Rui, H; Jiao, XM; Wang, M

CANCER RESEARCH, 2020; 80 (4):

科室
- - 订阅+
  - 更多科室
工具
服务